Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,788.80
(
0.70%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
104.65
(
0.45%
)
Bitcoin
80,326.03
(
-0.90%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122982
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 96689

Thursday, 06/03/2010 5:49:08 PM

Thursday, June 03, 2010 5:49:08 PM

Post# of 257566
PYMX MNTA: As noted in reply to your post on SI (http://siliconinvestor.advfn.com/readmsg.aspx?msgid=26587522 ), the cumbersome process that’s apparently required for PMX-60056 to reverse Lovenox is a boost, albeit a small one, for MNTA’s M118, which can be fully reversed with protamine (#msg-39146357). I consider this a small boost for M118 rather than a big boost because the target market for M118 is ACS and Lovenox is not a big factor in that market.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today